These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31939847)

  • 21. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
    Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
    Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ivabradine in Cardiovascular Disease Management Revisited: a Review.
    Chen C; Kaur G; Mehta PK; Morrone D; Godoy LC; Bangalore S; Sidhu MS
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):1045-1056. PubMed ID: 33411112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal Heart Rate Modulation Using Ivabradine.
    Imamura T; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):717-721. PubMed ID: 34276025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure.
    Kakehi K; Iwanaga Y; Watanabe H; Sonobe T; Akiyama T; Shimizu S; Yamamoto H; Miyazaki S
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):387-396. PubMed ID: 30786751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
    Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of post-systolic wall thickening into ejectional thickening by selective heart rate reduction during myocardial stunning.
    Lucats L; Ghaleh B; Monnet X; Colin P; Bizé A; Berdeaux A
    Eur Heart J; 2007 Apr; 28(7):872-9. PubMed ID: 17376788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heart rate control in patients with sepsis and septic cardiomyopathy: the role of Ivabradine].
    Shen Z; Zhou Z; Fang H; Zhang Y; Wang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1393-1398. PubMed ID: 33463505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period.
    Dierckx R; Cleland JG; Parsons S; Putzu P; Pellicori P; Dicken B; Boyalla V; Clark AL
    JACC Heart Fail; 2015 Mar; 3(3):224-30. PubMed ID: 25650369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of heart rate and contractility to myocardial oxygen balance during exercise.
    Colin P; Ghaleh B; Monnet X; Su J; Hittinger L; Giudicelli JF; Berdeaux A
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H676-82. PubMed ID: 12399255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
    Xu X; Guo Y; Gao W; Huang M; Liu T; Li F
    Eur J Pediatr; 2023 May; 182(5):2265-2271. PubMed ID: 36869903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats.
    Riesen SC; Schober KE; Cervenec RM; Bonagura JD
    J Vet Intern Med; 2011; 25(3):469-76. PubMed ID: 21418320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
    Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H
    J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
    Tardif JC; Ford I; Tendera M; Bourassa MG; Fox K;
    Eur Heart J; 2005 Dec; 26(23):2529-36. PubMed ID: 16214830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
    Schulz R; Rose J; Skyschally A; Heusch G
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
    Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
    Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
    Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.